SomnoMed Limited (SOM.AX)
AUD 0.43
(0.0%)
AUD 0.43
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 91.65 Million | 83.61 Million | 72.58 Million | 62.7 Million | 57.29 Million | 58.89 Million |
| Cost of Revenue | 36.51 Million | 37.84 Million | 33.42 Million | 28.8 Million | 27.28 Million | 24.31 Million |
| Gross Profit | 55.13 Million | 45.76 Million | 39.15 Million | 33.9 Million | 30.01 Million | 34.57 Million |
| Operating Expenses | 58.97 Million | 49.84 Million | 43.28 Million | 34.55 Million | 30.95 Million | 33.78 Million |
| Selling, General and Administrative Expenses | 57.67 Million | 49.13 Million | 42.3 Million | 33.59 Million | 30.05 Million | 32.2 Million |
| Research and Development Expenses | 1.3 Million | 705.85 Thousand | 978.38 Thousand | 958.17 Thousand | 904.29 Thousand | 1.05 Million |
| Other Expenses | - | -347.94 Thousand | 1.01 Million | 586.26 Thousand | 2.14 Million | 590.00 |
| Cost and Expenses | 95.49 Million | 87.68 Million | 76.71 Million | 63.35 Million | 58.23 Million | 58.1 Million |
| Operating Income | -3.84 Million | -4.07 Million | -4.13 Million | -651.38 Thousand | -940.98 Thousand | 918.45 Thousand |
| Interest Expense | 3.16 Million | 2.62 Million | 380.32 Thousand | 469.18 Thousand | 473.09 Thousand | 205.27 Thousand |
| Income Tax Expense | 971.1 Thousand | 821.63 Thousand | 930.6 Thousand | 349.16 Thousand | 1.18 Million | 646.61 Thousand |
| Earnings before Tax | -11.27 Million | -7.04 Million | -3.49 Million | -733.89 Thousand | 746.99 Thousand | 607.23 Thousand |
| Net Income | -12.24 Million | -7.99 Million | -4.43 Million | -1.19 Million | -1.11 Million | -39.38 Thousand |
| Earnings Per Share Basic | -0.10 | -0.10 | -0.05 | -0.01 | -0.02 | -0.00 |
| Earnings Per Share Diluted | -0.10 | -0.10 | -0.05 | -0.01 | -0.02 | -0.00 |
| Weighted Average Shares Outstanding | 120.71 Million | 82.14 Million | 82.14 Million | 82 Million | 66.01 Million | 70.78 Million |
| Weighted Average Shares Outstanding (Diluted) | 120.71 Million | 82.14 Million | 82.14 Million | 82 Million | 66.01 Million | 70.78 Million |
| Gross Margin | 0.60 | 0.55 | 0.54 | 0.54 | 0.52 | 0.59 |
| EBIT Margin | -0.03 | 0.01 | -0.00 | 0.05 | 0.04 | 0.05 |
| Profit Margin | -0.13 | -0.10 | -0.06 | -0.02 | -0.02 | -0.00 |
| EBITDA | -2.32 Million | 698.39 Thousand | 820.82 Thousand | 3.57 Million | 4.3 Million | 3.11 Million |
| Earnings Before Tax Margin | -0.04 | -0.05 | -0.06 | -0.01 | -0.02 | 0.02 |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 46.53 Million | 91.65 Million | 45.11 Million | 43.65 Million | 83.61 Million | 39.96 Million |
| Cost of Revenue | 22.34 Million | 42.29 Million | 20.47 Million | 20.17 Million | 37.84 Million | 17.67 Million |
| Gross Profit | 24.19 Million | 49.35 Million | 24.63 Million | 23.47 Million | 45.76 Million | 22.28 Million |
| Operating Expenses | 28.51 Million | 57.67 Million | 29.15 Million | 25.47 Million | 49.84 Million | 24.36 Million |
| Selling, General and Administrative Expenses | 28.51 Million | - | 28.57 Million | 25.13 Million | - | 24 Million |
| Research and Development Expenses | 594.06 Thousand | - | 581.43 Thousand | 346.81 Thousand | - | 359.04 Thousand |
| Other Expenses | - | - | - | - | -347.94 Thousand | - |
| Cost and Expenses | 50.85 Million | 99.96 Million | 49.63 Million | 45.65 Million | 87.68 Million | 42.03 Million |
| Operating Income | -4.32 Million | -8.31 Million | -4.51 Million | -1.99 Million | -4.07 Million | -2.07 Million |
| Interest Expense | 1.67 Million | 3.16 Million | 1.49 Million | 2.12 Million | 2.62 Million | 505.56 Thousand |
| Income Tax Expense | 170.06 Thousand | 971.1 Thousand | 801.03 Thousand | -1554.00 | 821.63 Thousand | 823.19 Thousand |
| Earnings before Tax | -5.72 Million | -11.27 Million | -5.54 Million | -4.16 Million | -7.04 Million | -2.88 Million |
| Net Income | -5.89 Million | -12.24 Million | -6.34 Million | -4.25 Million | -7.99 Million | -3.74 Million |
| Earnings Per Share Basic | -0.05 | - | -0.05 | -0.04 | - | -0.03 |
| Earnings Per Share Diluted | -0.05 | - | -0.05 | -0.04 | - | -0.03 |
| Weighted Average Shares Outstanding | 120.75 Million | 120.71 Million | 120.79 Million | 111.82 Million | 82.14 Million | 111.82 Million |
| Weighted Average Shares Outstanding (Diluted) | 120.75 Million | 120.71 Million | 120.79 Million | 111.82 Million | 82.14 Million | 111.82 Million |
| Gross Margin | 0.52 | 0.54 | 0.55 | 0.54 | 0.55 | 0.56 |
| EBIT Margin | -0.03 | - | -0.04 | 0.02 | - | 0.01 |
| Profit Margin | -0.13 | -0.13 | -0.14 | -0.10 | -0.10 | -0.09 |
| EBITDA | -1.44 Million | - | -1.61 Million | 759.56 Thousand | - | 284.76 Thousand |
| Earnings Before Tax Margin | -0.09 | -0.09 | -0.10 | -0.05 | -0.05 | -0.05 |
ASTERDM
BEEKAY
000501
8173
013360
CHYPF